Quick Answer
Praxis Precision Medicines, Inc. reported Total Revenue of $0.00 for the year ending 2025.
- Praxis Precision Medicines, Inc. showed a decrease of -100.0% in Total Revenue from 2024 to 2025.
- This data is from Praxis Precision Medicines, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $0.00 | Q2 2022: $0.00 | Q3 2022: $0.00 | Q1 2023: $683.0 thousand | Q2 2023: $781.0 thousand | Q3 2023: $468.0 thousand | Q1 2024: $431.0 thousand | Q2 2024: $357.0 thousand | Q3 2024: $302.0 thousand | Q1 2025: $0.00 | Q2 2025: $0.00 | Q3 2025: $0.00.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $8.55 million | Fiscal year 2023: $2.45 million | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: